More trial data backs Merck's cervical cancer shot (Reuters)
Reuters - New data from a combined analysis of four Phase II/III studies involving more than 20,000 women confirm the effectiveness of Merck & Co Inc's cervical cancer vaccine Gardasil, researchers said on Thursday.
Source: news.yahoo.com
# posted by Network @ 4:00 AM